Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000461833 | SCV000563842 | likely pathogenic | Tay-Sachs disease | 2016-12-02 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 11-13 of the HEXA gene. Additionally, this creates a premature translational stop signal in the last exon of the HEXA mRNA. While this is not anticipated to result in nonsense mediated decay, it is expected to replace the last 146 amino acids of the HEXA protein by 13 unrelated ones. This deletion results in the loss of most of domain II of the HEXA protein that is required for dimerization of the HEXA protein and the conformation of its active site and includes many pathogenic variants (PMID: 7837766, 16088929, 18490185). In summary, this sequence change is a gross deletion that is expected to result in a nonfunctional HEXA protein. However, experimental studies have not been done to prove that conclusively. For these reasons, it has been classified as Likely Pathogenic. |